Lam F Y, Ferrell W R
Institute of Physiology, University of Glasgow, Scotland, UK.
Agents Actions. 1990 Nov;31(3-4):298-307. doi: 10.1007/BF01997623.
Substance P (SP) injected into the synovial cavity of the rat knee resulted in an inflammatory response as measured by plasma protein extravasation into the joint capsule. This response was dose dependent over the range of approximately 4 microM to approximately 200 microM. Part of this inflammatory response was mediated via mast cells as pre-treatment of the animals with a mast cell degranulator (compound 48/80) resulted in a 66% reduction of the response. A direct effect of SP on the vascular receptors may also contribute to the inflammatory response as pre-treatment with the substance P antagonist (SPA) D-Pro4 D-Trp7,9,10 SP4-11 also reduces the inflammatory response. Intra-articular injections of the H1 blocker diphenhydramine or the H2 blocker cimetidine significantly blocked the SP-induced inflammatory response. The 5-hydroxytryptamine (5-HT) antagonist methysergide proved to be even more potent in blocking the SP-induced inflammatory response. No synergistic inhibition was observed with combinations of the different antagonists. Intra-articular injections of 5-HT elicited a much more pronounced inflammatory response than that produced by a 10-fold higher concentration of histamine. The results suggest that SP produces increased vascular permeability partly via direct actions on the blood vessels and partly via mast cells. The inflammatory response occurring via mast cells appears to be mediated by histamine and to a greater extent by 5-HT.
将P物质(SP)注入大鼠膝关节滑膜腔会引发炎症反应,这可通过血浆蛋白渗入关节囊来衡量。在大约4微摩尔至大约200微摩尔的范围内,这种反应呈剂量依赖性。这种炎症反应部分是通过肥大细胞介导的,因为用肥大细胞脱颗粒剂(化合物48/80)对动物进行预处理会使反应降低66%。SP对血管受体的直接作用也可能导致炎症反应,因为用P物质拮抗剂(SPA)D - Pro4 D - Trp7,9,10 SP4 - 11进行预处理也会降低炎症反应。关节内注射H1阻滞剂苯海拉明或H2阻滞剂西咪替丁可显著阻断SP诱导的炎症反应。5 - 羟色胺(5 - HT)拮抗剂麦角新碱在阻断SP诱导的炎症反应方面甚至更有效。不同拮抗剂联合使用未观察到协同抑制作用。关节内注射5 - HT引发的炎症反应比10倍浓度更高的组胺引发的炎症反应更明显。结果表明,SP部分通过对血管的直接作用,部分通过肥大细胞导致血管通透性增加。通过肥大细胞发生的炎症反应似乎由组胺介导,且在更大程度上由5 - HT介导。